Novo Nordisk A/S Common Stock (NVO) Operating Expenses & History | Stock Alarm

Demo Sign up Log In

Novo Nordisk A/S Common Stock · Operating Expenses

NVO Operating Expenses

Latest reportedkr 123.58B DKKperiod endingJun 30, 2026

NVO Operating Expenses · DKK (kr 1.35B → kr 123.58B)

Annual operating expenses

High-resolution chart · PNG

NVO operating expenses history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Operating Expenses — Annual fiscal periods (DKK)
Period ending	Operating Expenses (DKK)
Dec 31, 2025	122,618,000,000
Dec 31, 2024	117,542,000,000
Dec 31, 2023	93,922,000,000
Dec 31, 2022	73,697,000,000
Dec 31, 2021	58,498,000,000
Dec 31, 2020	51,888,000,000
Dec 31, 2019	49,450,000,000
Dec 31, 2018	46,966,000,000
Dec 31, 2017	45,097,000,000
Dec 31, 2016	46,165,000,000
Dec 31, 2015	42,295,000,000
Dec 31, 2014	39,752,000,000
Dec 31, 2013	37,939,000,000
Dec 31, 2012	35,087,000,000
Dec 31, 2011	31,383,000,000
Dec 31, 2010	30,205,000,000
Dec 31, 2009	25,707,000,000
Dec 31, 2008	23,129,941,000
Dec 31, 2007	23,130,622,000
Dec 31, 2006	20,042,678,000
Dec 31, 2005	16,472,300,000
Dec 31, 2004	14,098,184,000
Dec 31, 2003	12,747,781,000
Dec 31, 2002	12,555,822,000
Dec 31, 2001	12,155,085,000
Dec 31, 2000	12,192,224,000
Dec 31, 1999	9,891,847,000
Dec 31, 1998	8,999,425,000
Dec 31, 1997	9,928,179,000
Dec 31, 1996	8,756,511,000
Dec 31, 1995	8,010,961,000
Dec 31, 1994	7,844,361,000
Dec 31, 1993	4,793,873,000
Dec 31, 1992	6,985,683,000
Dec 31, 1991	3,630,297,650
Dec 31, 1990	3,154,273,600
Dec 31, 1989	2,804,223,000
Dec 31, 1988	1,976,962,400
Dec 31, 1987	1,790,542,050
Dec 31, 1986	224,680,500
Dec 31, 1985	1,351,771,200

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.